MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAYER, P.
Right arrow Articles by HUCHO, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAYER, P.
Right arrow Articles by HUCHO, F.

Molecular Pharmacology, Vol 12, 958-965, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

Selective Labeling of Anionic Binding Sites of the Acetylcholinesterase from Torpedo californica with a Photoaffinity Label

P. LAYER 1, H. R. KIEFER 1, and F. HUCHO 1

1 Fachbereich Biologie, Universität Konstanz, 775 Konstanz, German Federal Republic, and Basel Institute for Immunology, 4058 Basel, Switzerland

The synthesis of 4-azido-2-nitrobenzyltrimethylammonium fluoroborate, a photoaffinity label for cholinergic ligand binding sites, is described. The effect of this compound on acetylcholinesterase from Torpedo californica electric tissue has been investigated. In the dark it inhibits the enzyme reversibly, with a mixed competitive-noncompetitive mechanism (Ki = 7 µM). After irradiation at a wavelength of about 350 nm, the compound binds irreversibly and highly specifically to anionic binding sites of the enzyme. This was shown by experiments with the radioactive label and with cholinergic ligands containing quaternary ammonium groups, which protect the enzyme against inactivation and incorporation of the label. Experiments with Tetram and its triethyl derivative indicate that mainly the anionic subsite within the active site is labeled. After protection of the active site with edrophonium or carbamoylcholine, a peripheral anionic site can be blocked and labeled selectively with the photoaffinity label. This labeling of the peripheral site alters the reversible inhibition by the photolabel in the dark from a mixed competitive-noncompetitive mechanism to a purely competitive pattern (Ki = 16 µM for competition of the photoaffinity label in the dark with the substrate acetylthiocholine).

Note:
ACKNOWLEDGMENT We gratefully acknowledge support and review of the manuscript by Dr. H. Sund.

Submitted on February 9, 1976
Accepted on June 11, 1976







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics